Research Site [clinicaltrials_resource:d3b83a2f047e1cec01b84754d8ef6a1d]
clinicaltrials:NCT01226316clinicaltrials:NCT01248949clinicaltrials:NCT02000947clinicaltrials:NCT02054130A Phase 1, Open-label Study to Evaluate the Safety and Tolerability of MEDI0680 (AMP-514) in Combination With MEDI4736 in Subjects With Advanced Malignancies [clinicaltrials:NCT02118337]clinicaltrials:NCT02238483clinicaltrials:NCT02264678
location [clinicaltrials_vocabulary:location]
Research Site [clinicaltrials_resource:d3b83a2f047e1cec01b84754d8ef6a1d]
Bio2RDF identifier
d3b83a2f047e1cec01b84754d8ef6a1d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d3b83a2f047e1cec01b84754d8ef6a1d
address [clinicaltrials_vocabulary:address]
status [clinicaltrials_vocabulary:status]
Recruiting
identifier
clinicaltrials_resource:d3b83a2f047e1cec01b84754d8ef6a1d
title
Research Site
@en
type
label
Research Site [clinicaltrials_resource:d3b83a2f047e1cec01b84754d8ef6a1d]
@en